![](/img/cover-not-exists.png)
Visible disease at baseline accelerates time to exit from MRI-based active surveillance
Stavrinides, V., Giganti, F., Orczyk, C., Punwani, S., Allen, C., Kirkham, A., Freeman, A., Whitaker, H., Emberton, M., Moore, C.M.Volume:
18
Journal:
European Urology Supplements
DOI:
10.1016/s1569-9056(19)30448-8
Date:
March, 2019
File:
PDF, 87 KB
2019